300760 迈瑞医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)12.19822.00433.85035.60132.603
总资产报酬率 ROA (%)7.99114.03822.31424.46522.646
投入资产回报率 ROIC (%)10.36218.24928.10829.45027.081

边际利润分析
销售毛利率 (%)60.83460.31663.11264.17864.153
营业利润率 (%)31.36529.43035.70237.41536.194
息税前利润/营业总收入 (%)33.46628.27734.36234.79934.587
净利润/营业总收入 (%)28.43825.39331.96733.14631.650

收益指标分析
经营活动净收益/利润总额(%)97.79099.99397.00299.46096.214
价值变动净收益/利润总额(%)0.3701.1931.5010.535-0.241
营业外收支净额/利润总额(%)-0.183-1.250-0.708-0.453-0.337

偿债能力分析
流动比率 (X)2.3572.3632.4602.6602.600
速动比率 (X)1.9031.9322.0032.2662.258
资产负债率 (%)25.47327.42828.04430.44231.546
带息债务/全部投入资本 (%)7.0386.4494.9685.00110.605
股东权益/带息债务 (%)1,228.8801,292.6641,660.0621,672.748771.172
股东权益/负债合计 (%)261.925234.342225.719226.706216.876
利息保障倍数 (X)15.506-35.796-31.547-14.219-23.285

营运能力分析
应收账款周转天数 (天)36.32035.84331.92830.67925.592
存货周转天数 (天)137.941133.028116.072115.130125.513